Trintellix affects the brain's serotonin system, the same system that most anxiety medications target. What makes it somewhat different from standard antidepressants is that it influences serotonin activity in more than one way, which researchers believe may help with both the emotional and cognitive sides of anxiety, such as constant worrying, difficulty concentrating, and feeling mentally stuck.
Depression and anxiety also share a lot of the same underlying brain chemistry, which is why antidepressants often help with anxiety too, even when they were not originally designed for it. This is not unique to Trintellix. Selective serotonin reuptake inhibitors (SSRIs) like sertraline (Zoloft) and escitalopram (Lexapro) are first-line treatments for anxiety disorders, even though they were developed as antidepressants. Trintellix has been studied through the same lens.
Researchers have also studied Trintellix in people with generalized anxiety disorder (GAD), meaning persistent, hard-to-control worry that is not caused by depression. The results here are more mixed, but there is still meaningful positive data.
A meta-analysis that pooled results from seven clinical trials found that Trintellix was associated with greater reductions in anxiety symptoms than placebo after eight weeks of treatment. The researchers concluded that the evidence supported its use for anxiety disorder, while also noting that more long-term studies would strengthen confidence in that conclusion.